Drug
Who makes lorlatinib?
2 companies list lorlatinib as a human prescription drug, including under the names Lorbrena. Forms: tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing lorlatinib
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | tablet, film coated | NDANDA210868 | 2 | 0 |
| U.S. Pharmaceuticals | tablet, film coated | NDANDA210868 | 1 | 0 |
Orange Book patents
4 unexpired patents list lorlatinib as the active ingredient, expiring between Mar 2033 and Oct 2038. Application holder: PFIZER INC.
Enquiry
Common questions
- Who makes lorlatinib?
- 2 companies list lorlatinib as a human prescription drug in the openFDA NDC Directory, led by Pfizer Laboratories Div Pfizer Inc, U.S. Pharmaceuticals. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.